SAO PAULO (Reuters) – Brazil’s health regulator Anvisa said on Monday that it has approved trials with a third dose of the AstraZeneca vaccine against COVID-19.
Anvisa said a third dose of the vaccine would be administered to 10,000 volunteers between 11 and 13 months after the second shot.
(Reporting by Eduardo Simoes, writing by Carolina Mandl; Editing by Gareth Jones)
